Cytotoxic CD8+ T cells mediate tumor cell killing by recognizing tumor neoantigens and enhanced CD8+ T cell infiltration into tumors, in particular those with a high tumor mutational burden (TMB), is associated with better prognosis in almost all solid cancers (36). This evidence concerns the gene CD8A and neoplasm.